Product Specifications Peptide: GLP-1/GIP/GLUCAGON Concentration: 20mg per vial Grade: Research-Grade Storage: Maintain according to standard peptide laboratory protocols The 20mg format is optimized for mid-scale to large-scale studies, multi-dose trials, and mechanistic experiments
The IGF-1 component is unique and theoretically addresses the lean mass loss seen with all current GLP-1 therapies
Data availability The datasets generated and analyzed during the current study are available in the U.S
CagriSema may become an important Novo Nordisk follow-up platform if the amylin-plus-GLP-1 combination proves durable and tolerable
Dr Dinesh Mahendran, Consultant Endocrinologist at The Metabolic Clinic, was invited to share insights on CNA938 on the complex relationship between obesity, hormones, stress and mental health, and explains why weight gain is often driven by metabolic and hormonal factors rather than willpower alone
In many ways, this is a reminder of what specialty does best: meeting people where they are and helping them move forward
